Cargando…

Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial

BACKGROUND: Photodegradation of certain vitamins such as riboflavins, carotinoids, tocopherol, and folate has been well-documented. Previous observations suggest that ultraviolet (UV) radiation may cause folate deficiency. This is of great importance since folate deficiency is also known to be linke...

Descripción completa

Detalles Bibliográficos
Autores principales: Gambichler, Thilo, Bader, Armin, Sauermann, Kirsten, Altmeyer, Peter, Hoffmann, Klaus
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC60660/
https://www.ncbi.nlm.nih.gov/pubmed/11737876
http://dx.doi.org/10.1186/1471-5945-1-8
_version_ 1782120120684904448
author Gambichler, Thilo
Bader, Armin
Sauermann, Kirsten
Altmeyer, Peter
Hoffmann, Klaus
author_facet Gambichler, Thilo
Bader, Armin
Sauermann, Kirsten
Altmeyer, Peter
Hoffmann, Klaus
author_sort Gambichler, Thilo
collection PubMed
description BACKGROUND: Photodegradation of certain vitamins such as riboflavins, carotinoids, tocopherol, and folate has been well-documented. Previous observations suggest that ultraviolet (UV) radiation may cause folate deficiency. This is of great importance since folate deficiency is also known to be linked with the development of neural tube defects. To investigate the influence of UVA radiation on serum folate levels in vivo, we conducted a two-group randomised controlled trial on healthy subjects. MATERIAL AND METHODS: Twenty-four healthy volunteers with skin type II were enrolled into the study. Eight volunteers of the study population were randomly assigned to the control group. UVA irradiation was administered with an air-conditioned sunbed. Blood samples were taken from all volunteers at baseline (T1), 30 min after the first UVA exposure (T2), and at the end of the study 24 h after the sixth UV exposure (T3). The volunteers had two UVA exposures weekly within three weeks (cumulative UVA dose: 96 J/cm(2)). Volunteers of the control group had no UVA exposures. Serum folate was analysed with an automated immunoassay system. RESULTS: At all times of blood collection the differences between serum folate levels were insignificant (P > 0.05), except of the non-exposed controls at T2 (P < 0.05). We did not observed significant differences of folate levels between UVA exposed and non-exposed volunteers (P > 0.05). CONCLUSIONS: Our data suggest that both single and serial UVA exposures do not significantly influence serum folate levels of healthy subjects. Therefore, neural tube defects claimed to occur after periconceptual UVA exposure are probably not due to UVA induced folate deficiency.
format Text
id pubmed-60660
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-606602001-12-09 Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial Gambichler, Thilo Bader, Armin Sauermann, Kirsten Altmeyer, Peter Hoffmann, Klaus BMC Dermatol Research Article BACKGROUND: Photodegradation of certain vitamins such as riboflavins, carotinoids, tocopherol, and folate has been well-documented. Previous observations suggest that ultraviolet (UV) radiation may cause folate deficiency. This is of great importance since folate deficiency is also known to be linked with the development of neural tube defects. To investigate the influence of UVA radiation on serum folate levels in vivo, we conducted a two-group randomised controlled trial on healthy subjects. MATERIAL AND METHODS: Twenty-four healthy volunteers with skin type II were enrolled into the study. Eight volunteers of the study population were randomly assigned to the control group. UVA irradiation was administered with an air-conditioned sunbed. Blood samples were taken from all volunteers at baseline (T1), 30 min after the first UVA exposure (T2), and at the end of the study 24 h after the sixth UV exposure (T3). The volunteers had two UVA exposures weekly within three weeks (cumulative UVA dose: 96 J/cm(2)). Volunteers of the control group had no UVA exposures. Serum folate was analysed with an automated immunoassay system. RESULTS: At all times of blood collection the differences between serum folate levels were insignificant (P > 0.05), except of the non-exposed controls at T2 (P < 0.05). We did not observed significant differences of folate levels between UVA exposed and non-exposed volunteers (P > 0.05). CONCLUSIONS: Our data suggest that both single and serial UVA exposures do not significantly influence serum folate levels of healthy subjects. Therefore, neural tube defects claimed to occur after periconceptual UVA exposure are probably not due to UVA induced folate deficiency. BioMed Central 2001-11-20 /pmc/articles/PMC60660/ /pubmed/11737876 http://dx.doi.org/10.1186/1471-5945-1-8 Text en Copyright © 2001 Gambichler et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research Article
Gambichler, Thilo
Bader, Armin
Sauermann, Kirsten
Altmeyer, Peter
Hoffmann, Klaus
Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial
title Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial
title_full Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial
title_fullStr Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial
title_full_unstemmed Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial
title_short Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial
title_sort serum folate levels after uva exposure: a two-group parallel randomised controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC60660/
https://www.ncbi.nlm.nih.gov/pubmed/11737876
http://dx.doi.org/10.1186/1471-5945-1-8
work_keys_str_mv AT gambichlerthilo serumfolatelevelsafteruvaexposureatwogroupparallelrandomisedcontrolledtrial
AT baderarmin serumfolatelevelsafteruvaexposureatwogroupparallelrandomisedcontrolledtrial
AT sauermannkirsten serumfolatelevelsafteruvaexposureatwogroupparallelrandomisedcontrolledtrial
AT altmeyerpeter serumfolatelevelsafteruvaexposureatwogroupparallelrandomisedcontrolledtrial
AT hoffmannklaus serumfolatelevelsafteruvaexposureatwogroupparallelrandomisedcontrolledtrial